Studies
What is a Study?In this study, we developed a workflow to compute a modified version of the Cumulative Allele Probability (CAP) for genes in the COVID-19 disease map and the “Drug Risk Probability” (DRP) score for drugs targeting genes in the map (Schärfe et al., 2017). The CAP score considers the number of pharmacogenomic variants and their frequency in the population for a specific gene. The DRP score combines the CAP scores for all drug target genes for a specific drug. For this, we use allelic frequencies ...